Pharmaceutical Distribution
•51 stocks
•
Total Market Cap: Loading...
Market Cap Distribution
Price Performance Heatmap
5Y Price (Market Cap Weighted)
All Stocks (51)
%
| Company | Market Cap | Price |
|---|---|---|
|
Amazon Pharmacy represents pharmaceutical distribution and direct health-product services.
|
$2.30T |
$216.37
-4.35%
|
|
CVS is a leading pharmaceutical distributor to CVS Pharmacy stores and customers, underpinning the drug supply and reimbursement ecosystem.
|
$98.55B |
$77.90
-0.33%
|
|
Pharmaceutical Distribution is McKesson's core business, providing large-scale wholesale distribution of medicines and healthcare products.
|
$95.72B |
$765.08
-0.68%
|
|
Pharmaceutical distribution and temperature-controlled healthcare logistics are a strategic growth area.
|
$70.89B |
$83.72
+1.18%
|
|
Specific pharma distribution is a distinct investable theme beyond general logistics.
|
$61.64B |
$318.00
+0.45%
|
|
Health division includes drugstores/pharmaceutical distribution and related services.
|
$33.55B |
$93.76
-1.03%
|
|
Allivet's online pet pharmacy operations align with Pharmaceutical Distribution as a service/dispensing channel.
|
$28.76B |
$54.24
-0.40%
|
|
Owns pharmacies and pharmacy fulfillment, enabling prescription distribution.
|
$12.08B |
$53.95
-7.45%
|
|
Walgreens Boots Alliance directly distributes prescription drugs and pharmacy products to its stores and patients, aligning with Pharmaceutical Distribution.
|
$10.36B |
$11.98
|
|
Healthcare distribution capabilities evidenced by NHS contract and healthcare vertical expansion.
|
$6.05B |
$52.89
-0.11%
|
|
BrightSpring's PharMerica-backed operations position them as a provider of pharmaceutical distribution services to healthcare facilities and patients.
|
$4.81B |
$28.18
+2.12%
|
|
Direct pharmaceutical distribution and supply of infusion therapies to patients via home/infusion centers.
|
$4.37B |
$26.71
-0.71%
|
|
Mirum is actively commercializing its medicines, including international markets, indicating a pharmaceutical distribution/ commercialization capability.
|
$3.64B |
$73.57
-0.65%
|
|
AvKARE government/institutional distribution channel represents a key service/sales channel.
|
$3.12B |
$9.97
-3.11%
|
|
Woodwork represents a healthcare/pharmaceutical distribution initiative (men's health ED meds) expanding Grindr's service mix.
|
$2.34B |
$11.96
-4.24%
|
|
CC Pharma distribution in Germany indicates Pharmaceutical Distribution as a direct service channel.
|
$1.89B |
$1.72
-14.43%
|
|
Provides pharmaceutical distribution and medication dispensation services to LTCFs, including unit-dose packaging and billing processing.
|
$1.48B |
$23.41
-2.17%
|
|
ImprimisRx compounding segment provides pharmaceutical compounding and distribution services to eye care professionals, a significant revenue line.
|
$1.38B |
$37.48
-8.02%
|
|
Eton leverages specialty pharmacy distribution (Optime Care) and licensing deals, forming a Pharmaceutical Distribution revenue stream.
|
$534.47M |
$19.93
+0.66%
|
|
Distributes and manages pharmaceuticals within its health plans and oncology network.
|
$484.16M |
$6.55
-0.30%
|
|
Cryoport's services support regulated pharmaceutical distribution and clinical-trial logistics, aligning with pharmaceutical distribution workflows.
|
$476.30M |
$9.41
-0.95%
|
|
Online sales and distribution of medicines and health products via AHG's platforms.
|
$383.46M |
$1.60
-6.98%
|
|
OMI distributes pharmaceutical products to hospitals and healthcare providers, aligning with Pharmaceutical Distribution.
|
$365.45M |
$4.77
-1.24%
|
|
SelectRx and healthcare services include pharmaceutical distribution for members.
|
$322.99M |
$1.87
-2.09%
|
|
The company relies on pharmaceutical distribution channels and IDN networks for FUROSCIX, reflecting a Pharmaceutical Distribution capability.
|
$299.33M |
$5.67
|
|
In-house pharmaceutical distribution via LifeMD's National Pharmacy.
|
$280.41M |
$6.17
-5.95%
|
|
Upsher Smith acquisition provides a pharmaceutical distribution capability, generating revenue from scheduled migraine products Zembrace and Tosymra.
|
$155.21M |
$21.19
-4.46%
|
|
Exclusive ITV-1 distribution agreements in multiple regions indicate pharmaceutical distribution as a core revenue stream.
|
$109.82M |
$0.32
|
|
Pharmaceutical distribution capabilities for cannabis products via pharmacies and international exports.
|
$72.92M |
$1.60
-4.76%
|
|
Compounded pharmaceutical products are distributed through pharmacies, aligning with Pharmaceutical Distribution.
|
$52.85M |
$0.18
-3.80%
|
|
The company manufactures and distributes branded prescription products to hospital channels, corresponding to the 'Pharmaceutical Distribution' theme.
|
$51.62M |
$3.45
-2.27%
|
|
Karyopharm generates net product revenue from XPOVIO in the US, indicating involvement in pharmaceutical distribution.
|
$47.52M |
$5.50
-6.94%
|
|
Pharmaceutical Distribution (repeat entry reflecting core business).
|
$37.68M |
$4.38
-8.68%
|
|
Ongoing pharmaceutical distribution operations (SkyPharm/Cana network) constitute a core distribution channel.
|
$30.76M |
$1.07
-8.15%
|
|
LOI to acquire VitorganAmerica.shop, a distributor of biomolecular health products, maps to pharmaceutical distribution.
|
$28.46M |
$0.30
+20.00%
|
|
NXPL distributes OPKO pharmaceuticals in China and related products, constituting pharmaceutical distribution.
|
$22.64M |
$0.87
-0.51%
|
|
CJMB delivers pharmaceutical distribution capabilities, including temperature-controlled logistics for vaccines/biologics.
|
$19.02M |
$4.28
-3.39%
|
|
Pharmaceutical Distribution: platform to offer GLP-1 therapies via AllurionMeds (drug distribution service).
|
$14.92M |
$2.00
-6.98%
|
|
RxConnect supports pharmaceutical distribution through a network of partner pharmacies and payer workflows.
|
$14.56M |
$2.36
-7.45%
|
|
Arbli commercialization and distribution milestones imply direct involvement in pharmaceutical distribution.
|
$9.20M |
$0.70
-6.52%
|
|
Marley Drug functions as a pharmaceutical distribution platform via an online pharmacy, fitting Pharmaceutical Distribution.
|
$7.83M |
$0.75
|
|
Infusion pharmacy services align with Pharmaceutical Distribution.
|
$6.85M |
$0.06
+23.91%
|
|
The company maintains a regional distribution network for its pharmaceutical products, indicating pharmaceutical distribution activity.
|
$6.17M |
$1.89
-2.07%
|
|
Company distributes pharmaceutical products across its network, aligning with Pharmaceutical Distribution.
|
$5.77M |
$1.48
-1.47%
|
|
Active pharmaceutical distribution to pharmacies for medical cannabis products aligns with pharmaceutical distribution.
|
$4.31M |
$1.93
-4.46%
|
|
MOD is a medical/pharmaceutical distribution subsidiary; the company distributes medical supplies and pharmaceuticals.
|
$4.27M |
$1.50
+5.65%
|
|
Pharmaceutical distribution/retail through company-operated pharmacies.
|
$3.75M |
$0.15
|
|
Lucemyra assets contribute revenue via distribution, capturing Pharmaceutical Distribution.
|
$2.98M |
$0.45
|
|
Sales of Patented Drugs segment suggests pharmaceutical distribution-related activity.
|
$1.98M |
$0.75
-6.14%
|
|
Distributes radiopharmaceuticals; pharmaceutical distribution service for nuclear medicine products.
|
$518499 |
$0.05
-7.75%
|
|
Distribution of pharmaceutical products and health solutions (including nutraceuticals) across regions.
|
$229298 |
$0.00
|
Loading industry metrics...
Loading comparison data...
